NCT00010023
- Conditions
- Adenocarcinoma, Appendiceal Neoplasms, Bile Duct Diseases, +70 more
- Locations
-
- NYU Cancer Institute at New York University Medical Center New York, United States
Clinical trial condition
Bile Duct Neoplasms
Explore clinical trials studying Bile Duct Neoplasms. Study availability and eligibility vary by location and protocol.
169 public trials
27 recruiting studies
Bile Duct Neoplasms trial results
NCT00003548
- Conditions
- Adenocarcinoma, Adnexal Diseases, Anus Diseases, +75 more
- Locations
-
- NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, United States
NCT00779688
- Conditions
- Bile Duct Cancer, Bile Duct Diseases, Bile Duct Neoplasms, +11 more
- Locations
-
- University of Colorado Hospital Aurora, Colorado, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- New York Presbyterian Hospital/Columbia University Medical Center New York, United States
- University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
NCT01153750
- Conditions
- Adenocarcinoma, Advanced or Metastatic Cholangiocellular Carcinoma and Bile Duct, Bile Duct Diseases, +11 more
- Locations
-
- Krankenhaus Nordwest Frankfurt am Main, Hesse, Germany
- University Hospital Dresden, Saxony, Germany
- University Hospital Schleswig-Holstein, Campus Kiel Kiel, Schleswig-Holstein, Germany
- Onkologische Schwerpunktpraxis Eppendorf Hamburg, Germany
NCT00049296
- Conditions
- AIDS-related Kaposi sarcoma, Adenocarcinoma, Anus Diseases, +155 more
- Locations
-
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT00628186
- Conditions
- Ampullary Cancer, Bile Duct Cancer, Bile Duct Diseases, +25 more
- Locations
-
- Wakayama Medical University , Second Department of Surgery 811-1 Kimiidera, Wakayama, Wakayama, Japan
NCT00579865
- Conditions
- Bile Duct Cancer, Bile Duct Diseases, Bile Duct Neoplasms, +12 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Active, Not Recruiting
Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer
NCT05277766
- Conditions
- Abdominal Neoplasms, Adenocarcinoma, Appendiceal Neoplasms, +37 more
- Locations
-
- UZ Ghent Ghent, East-Flanders, Belgium
Active, Not Recruiting
Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)
NCT06109779
- Conditions
- Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +14 more
- Locations
-
- Research Site Birmingham, Alabama, United States
- Research Site Phoenix, Arizona, United States
- Research Site Los Angeles, California, United States
- Research Site Orange, California, United States
Active, Not Recruiting
Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)
NCT06048133
- Conditions
- Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +12 more
- Locations
-
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
- University of Michigan Health System Ann Arbor, Michigan, United States
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
- University of Wisconsin Madison, Wisconsin, United States